Presentation is loading. Please wait.

Presentation is loading. Please wait.

| Slide 1 of 63 April 2007 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront.

Similar presentations


Presentation on theme: "| Slide 1 of 63 April 2007 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront."— Presentation transcript:

1 | Slide 1 of 63 April 2007 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront Cape Town, South Africa Date: 16 to 20 April 2007 Pharmaceutical Development

2 | Slide 2 of 63 April 2007 Pharmaceutical Development Workshop on paediatric dosage forms Presenter: Jean-Marc AIACHE Emeritus Professor, Auvergne University, Faculty of Pharmacy, 28 Place Henri Dunant Clermont-Ferrand, France

3 | Slide 3 of 63 April 2007 Pharmaceutical Development Outline and Objectives of presentation Presentation and discussion of the last guideline of EMEA Aim of the document Influences on the Administration of medicinal products. Developmental pharmacology. Routes of administration Drug dosage form in function of route of administration General considerations on the choice of excipient Conclusion

4 | Slide 4 of 63 April 2007

5 | Slide 5 of 63 April 2007

6 | Slide 6 of 63 April 2007

7 | Slide 7 of 63 April 2007

8 | Slide 8 of 63 April 2007

9 | Slide 9 of 63 April 2007

10 | Slide 10 of 63 April 2007

11 | Slide 11 of 63 April 2007

12 | Slide 12 of 63 April 2007

13 | Slide 13 of 63 April 2007

14 | Slide 14 of 63 April 2007

15 | Slide 15 of 63 April 2007

16 | Slide 16 of 63 April 2007 conclusion

17 | Slide 17 of 63 April 2007

18 | Slide 18 of 63 April 2007 Oral administration

19 | Slide 19 of 63 April 2007 Oral administration

20 | Slide 20 of 63 April 2007 Oral administration

21 | Slide 21 of 63 April 2007 Oral administration

22 | Slide 22 of 63 April 2007 Oral administration

23 | Slide 23 of 63 April 2007 Oral administration

24 | Slide 24 of 63 April 2007 Oral administration

25 | Slide 25 of 63 April 2007 Oral administration

26 | Slide 26 of 63 April 2007

27 | Slide 27 of 63 April 2007 Buccal dosage form

28 | Slide 28 of 63 April 2007 Buccal dosage form

29 | Slide 29 of 63 April 2007

30 | Slide 30 of 63 April 2007

31 | Slide 31 of 63 April 2007 Nasal dosage form

32 | Slide 32 of 63 April 2007 Buccal dosage forms

33 | Slide 33 of 63 April 2007

34 | Slide 34 of 63 April 2007 Rectal administration

35 | Slide 35 of 63 April 2007 Rectal administration

36 | Slide 36 of 63 April 2007

37 | Slide 37 of 63 April 2007 Topicals

38 | Slide 38 of 63 April 2007 Transdermal patches

39 | Slide 39 of 63 April 2007 Transdermal patches

40 | Slide 40 of 63 April 2007

41 | Slide 41 of 63 April 2007 Parenteral administration

42 | Slide 42 of 63 April 2007 Parenteral administration

43 | Slide 43 of 63 April 2007 Parenteral administration

44 | Slide 44 of 63 April 2007 Parenteral administration

45 | Slide 45 of 63 April 2007 Parenteral administration

46 | Slide 46 of 63 April 2007 Parenteral administration

47 | Slide 47 of 63 April 2007 Parenteral administration

48 | Slide 48 of 63 April 2007

49 | Slide 49 of 63 April 2007

50 | Slide 50 of 63 April 2007 Inhalation dosage forms

51 | Slide 51 of 63 April 2007 Inhalation dosage forms

52 | Slide 52 of 63 April 2007

53 | Slide 53 of 63 April 2007

54 | Slide 54 of 63 April 2007

55 | Slide 55 of 63 April 2007 Matrix for dosage forms

56 | Slide 56 of 63 April 2007 Matrix for dosage forms

57 | Slide 57 of 63 April 2007 Matrix for dosage forms

58 | Slide 58 of 63 April 2007 Preservatives Sweeteners. Fillers and solvents. Coloring agents. Coating materials

59 | Slide 59 of 63 April 2007

60 | Slide 60 of 63 April 2007

61 | Slide 61 of 63 April 2007 Household spoons droppers measuring spoons and cups cylindrical measuring spoons graduated pipettes and oral dosing syringes

62 | Slide 62 of 63 April 2007 Must be done with children, but carefully selected and well organized to recognize the different taste.

63 | Slide 63 of 63 April 2007 Pharmaceutical Development Summary and conclusion The choice of a dosage form as well as the excipients allowing the manufacturing process of this form, most to be done in function not only of the children disease but also to the possible side reaction of the parents or caregivers and children. The EMEA guideline may help the companies to reach this aim.


Download ppt "| Slide 1 of 63 April 2007 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront."

Similar presentations


Ads by Google